Financial Advantage’s Chemours CC Stock Holding History

Financial Advantage’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-40	Closed	–	–	44
2015 Q3	$0	Buy	+40	New	+$419	﹤0.01%	110

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CCM

Conatus Capital Management Greenwich, Connecticut $92.3M AUM 45.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Financial Advantage's CC Position: Q4 2015 in Review

Financial Advantage sold out of Chemours (CC) in Q4 2015, closing a stake of 40 shares.

Financial Advantage first reported a position in CC in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 438 funds tracked by Wall St. Rank hold CC as of Q4 2015.

Financial Advantage reported no remaining Chemours position as of Q4 2015 after selling out during the quarter.
Financial Advantage sold 40 Chemours shares in Q4 2015.
Financial Advantage first reported a position in Chemours in Q3 2015 and held it in 1 quarter.
Financial Advantage's Chemours position peaked at $0 in Q3 2015.
438 funds tracked by Wall St. Rank held Chemours as of Q4 2015.

Based on Financial Advantage's 13F filing for Q4 2015, filed 29 Jan 2016.